Effect of indoleamine 2,3-dioxygenase expressed by foetal fibroblasts on melanoma cells.
Skin cancer unit, Nantes University Hospital, Nantes, France.
Cécile
C
Frenard
CHU, immunodermatology lab, Hôtel Dieu, Nantes, France.|Inserm, CRCNA U892, Hôtel Dieu, Nantes, France.
Anne-Chantal
AC
Knol
Skin cancer unit, Nantes University Hospital, Nantes, France.
Marie
M
Lemoigne
Skin cancer unit, Nantes University Hospital, Nantes, France.
Amir
A
Khammari
Skin cancer unit, Nantes University Hospital, Nantes, France. brigitte.dreno@wanadoo.fr.
Brigitte
B
Dreno
D060890:B7-H1 Antigen / Q000378:metabolism*; D002478:Cells, Cultured; D018920:Coculture Techniques; D016207:Cytokines / Q000378:metabolism; D005347:Fibroblasts / Q000201:enzymology; D006801:Humans; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase / Q000378:metabolism*; D008285:Major Histocompatibility Complex; D008545:Melanoma / Q000276:immunology / Q000378:metabolism*
D060890:B7-H1 Antigen; C423236:CD274 protein, human; D016207:Cytokines; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase
fetal fibroblasts; indoleamine 2,3-dioxygenase; melanoma